Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | PDE2A | O00408 | 10/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976565 | 0.89 | PDE2A (0.43) | MAPK1PDE2A | |
| SCHEMBL974313 | 0.87 | PDE2A (0.38) | MAPK1PDE2AALDH1A1TSHRPOLB | |
| SCHEMBL976406 | 0.81 | LMNA (0.47) | MAPK1PDE2AALDH1A1LMNATSHR | |
| SCHEMBL3227894 | 0.81 | PDE2A (0.39) | PDE2A | |
| SCHEMBL5090639 | 0.78 | PDE2A (0.42) | MAPK1PDE2AALDH1A1LMNA | |
| SCHEMBL5096432 | 0.77 | ALDH1A1 (0.47) | MAPK1ALDH1A1TSHRPOLBKMT2A | |
| SCHEMBL4820670 | 0.77 | PDE2A (0.36) | MAPK1PDE2AALDH1A1TSHRPOLB | |
| SCHEMBL7000564 | 0.76 | PDE2A (0.35) | MAPK1PDE2A | |
| SCHEMBL3217156 | 0.76 | PDE2A (0.38) | PDE2A | |
| SCHEMBL973762 | 0.75 | PDE2A (0.41) | PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8974806-B2 | Method for producing aqueous active substance compositions of active substances that are hardly soluble in water | BASF AKTIENGESELLSCHAFT (DE) | 2015-03-10 | — | — | US | disclosed |
| US-8741324-B2 | Liquid pesticide compositions | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-8728504-B2 | Process for solubilizing hydrophobic active ingredients in aqueous medium | BASF SE (DE) | 2014-05-20 | — | — | US | disclosed |
| EP-2676680-A1 | Use of hydrophobin polypeptides as penetration enhancers | BASF SE (DE) | 2013-12-25 | — | — | EP | disclosed |
| US-8497230-B2 | Solid crop protection agents containing polyalkoxylate, method for their production and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-07-30 | — | — | US | disclosed |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| EP-1763300-B1 | USE OF ETHER GROUP-CONTAINING POLYMERS AS SOLUBILIZERS | BASF SE (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-20110312497-A1 | USE OF HYDROPHOBIN AS A SPREADING AGENT | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110195844-A1 | PROCESS FOR SOLUBILIZING HYDROPHOBIC ACTIVE INGREDIENTS IN AQUEOUS MEDIUM | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| EP-2308460-A1 | Composition comprising active agents and at least one nitrogen-containing hyper-branched polymer | BASF SE (DE) | 2011-04-13 | — | — | EP | disclosed |
| US-20070184983-A1 | Liquid pesticide compositions | BASF SE (DE) | 2007-08-09 | — | — | US | disclosed |
| WO-2007048851-A1 | SOLID CROP PROTECTION AGENTS CONTAINING POLYALKOXYLATE, METHOD FOR THEIR PRODUCTION AND USE THEREOF | BASF SE (DE) | 2007-05-03 | — | — | WO | disclosed |
| EP-1776010-A2 | METHOD FOR PRODUCING AQUEOUS ACTIVE SUBSTANCE COMPOSITIONS OF ACTIVE SUBSTANCES THAT ARE HARDLY SOLUBLE IN WATER | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-25 | — | — | EP | disclosed |
| EP-1773121-A1 | LIQUID PESTICIDE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-18 | — | — | EP | disclosed |
| EP-1756188-A1 | AMPHIPHILIC POLYMER COMPOSITIONS AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006125644-A1 | METHOD FOR DETERMINING PESTICIDE RESIDUES IN SOIL OR PLANT MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006084680-A1 | POLYMER COMPOSITIONS AND THEIR USE IN THE PRODUCTION OF ACTIVE OR EFFECTIVE INGREDIENT COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006015791-A2 | METHOD FOR PRODUCING AQUEOUS ACTIVE SUBSTANCE COMPOSITIONS OF ACTIVE SUBSTANCES THAT ARE HARDLY SOLUBLE IN WATER | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-16 | — | — | WO | disclosed |
| WO-2006002984-A1 | LIQUID PESTICIDE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-12 | — | — | WO | disclosed |
| WO-2005121201-A1 | AMPHIPHILIC POLYMER COMPOSITIONS AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312497-A1 | USE OF HYDROPHOBIN AS A SPREADING AGENT | PFN1, DSTN, CHN2 | MAPK1 3589/4885PDE2A 3375/4885ALDH1A1 3404/4885 |
| US-20110195844-A1 | PROCESS FOR SOLUBILIZING HYDROPHOBIC ACTIVE INGREDIENTS IN AQUEOUS MEDIUM | IDUA, PHOSPHO1, HDHD5 | MAPK1 477/4885PDE2A 3057/4885ALDH1A1 3286/4885 |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | MAPK1 2382/4885PDE2A 310/4885ALDH1A1 2770/4885 |
| US-20070184983-A1 | Liquid pesticide compositions | CBR3, BBC3, DDT | MAPK1 2845/4885PDE2A 2608/4885ALDH1A1 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.